Arsen Mikaelyan
- Hepatology top 2%
- Liver physiology and pathology 5
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 3
- Molecular Biology top 10%
- Glycosylation and Glycoproteins Research 2
- Gene expression and cancer classification 2
- Fibroblast Growth Factor Research 2
- Oncology top 10%
- Cancer Cells and Metastasis 3
- Cell Biology top 10%
-
- Growth Hormone and Insulin-like Growth Factors 3
-
- Pancreatic function and diabetes 3
- Co-authors
- Ju‐Seog LeeSnorri S. ThorgeirssonIn‐Sun ChuDiego F. CalvisiJeonghoon HeoPál Kaposi-NovákLouis LibbrechtFrederik Nevens
- Partner nations
- RussiaUnited StatesAustria
In The Last Decade
Arsen Mikaelyan
25 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Hepatology 487
- Cancer Research 381
- Molecular Biology 747
- Oncology 296
- Cell Biology 159
Countries citing papers authored by Arsen Mikaelyan
This map shows the geographic impact of Arsen Mikaelyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arsen Mikaelyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arsen Mikaelyan more than expected).
Fields of papers citing papers by Arsen Mikaelyan
This network shows the impact of papers produced by Arsen Mikaelyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arsen Mikaelyan. The network helps show where Arsen Mikaelyan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arsen Mikaelyan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 18 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 9 | |
| 9 | 2019 | 11 | |
| 10 | 2019 | 26 | |
| 11 | 2014 | 6 | |
| 12 | 2013 | 0 | |
| 13 | 2012 | 2 | |
| 14 | 2008 | 11 | |
| 15 | 2008 | 14 | |
| 16 | 2007 | 54 | |
| 17 | 2007 | 102 | |
| 18 | A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cellsbreakdown → | 2006 | 722 |
| 19 | 2004 | 370 | |
| 20 | 2004 | 11 |
About Arsen Mikaelyan
Arsen Mikaelyan is a scholar working on Hepatology, Cancer Research and Developmental Neuroscience, having authored 26 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver physiology and pathology (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Cells and Metastasis (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Pancreatic function and diabetes (3 papers), Glycosylation and Glycoproteins Research (2 papers), Gene expression and cancer classification (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Hepatology (487 citations), Cancer Research (381 citations) and Molecular Biology (747 citations). Arsen Mikaelyan has collaborated with scholars based in Russia, United States and Austria. Frequent co-authors include Ju‐Seog Lee, Snorri S. Thorgeirsson, In‐Sun Chu, Diego F. Calvisi, Jeonghoon Heo, Pál Kaposi-Novák, Louis Libbrecht, Frederik Nevens, Tania Roskams and Anthony J. Demetris. Their work appears in journals such as Nature Medicine, Nature Genetics and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.